Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Moodys
Chubb
Argus Health
Farmers Insurance
US Army
Daiichi Sankyo
Cerilliant
Cipla

Generated: June 21, 2018

DrugPatentWatch Database Preview

Fougera Pharms Inc Company Profile

« Back to Dashboard

What is the competitive landscape for FOUGERA PHARMS INC, and when can generic versions of FOUGERA PHARMS INC drugs launch?

FOUGERA PHARMS INC has twenty-eight approved drugs.

There are three US patents protecting FOUGERA PHARMS INC drugs.

There are forty-two patent family members on FOUGERA PHARMS INC drugs in twenty countries and twenty-one supplementary protection certificates in eleven countries.

Summary for Fougera Pharms Inc
International Patents:42
US Patents:3
Tradenames:15
Ingredients:15
NDAs:28

Drugs and US Patents for Fougera Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms Inc FLUOCINONIDE fluocinonide CREAM;TOPICAL 200735-001 Jul 14, 2014 AB RX No No ➤ Sign Up ➤ Sign Up
Fougera Pharms Inc GENTAMICIN SULFATE gentamicin sulfate CREAM;TOPICAL 062531-001 Jul 5, 1984 DISCN No No ➤ Sign Up ➤ Sign Up
Fougera Pharms Inc GENTAMICIN SULFATE gentamicin sulfate OINTMENT;TOPICAL 062533-001 Oct 5, 1984 AT RX No No ➤ Sign Up ➤ Sign Up
Fougera Pharms Inc FLUOCINOLONE ACETONIDE fluocinolone acetonide OINTMENT;TOPICAL 088168-001 Dec 16, 1982 AT RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for Fougera Pharms Inc

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
5,968,973 Method for treating hyperplasia ➤ Sign Up
6,197,808 Methods for treating hyperplasia ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Supplementary Protection Certificates for Fougera Pharms Inc Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
00550 Netherlands ➤ Sign Up PRODUCT NAME: MENGSEL VAN CATECHOLEN GEISOLEERD UIT EEN EXTRACT VAN GROENE THEE, CAMELLIA SINENSIS, L. O. KUNTZE MET ISOPROPYLMYRISTAAT; NATL. REGISTRATION NO/DATE: RVG 110904 20120920; FIRST REGISTRATION: DE 73486.00.00 20090831
2012 00040 Denmark ➤ Sign Up
90030-4 Sweden ➤ Sign Up PRODUCT NAME: TORRT EXTRAKT AV CAMELLIA SINENSIS (L.) O. KUNTZE, FOLIUM; NAT. REG. NO/DATE: 47136 20120405; FIRST REG.: DE 73486.00.00 20090831
C0077 France ➤ Sign Up PRODUCT NAME: EXTRAIT SEC RAFFINE DE FEUILLE DE THE VERT (CAMELLIA SINENSIS) (L.) O. KUNTZE QUANTIFIE EN GALLATE D'(-)-EPIGALLOCATECHINE; NAT. REGISTRATION NO/DATE: NL 41799 20120625; FIRST REGISTRATION: 73486.00.00 20090831
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Merck
Deloitte
Johnson and Johnson
US Army
QuintilesIMS
Argus Health
Farmers Insurance
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.